Search

Your search keyword '"German Centre for Infection Research ( DZIF )"' showing total 57 results

Search Constraints

Start Over You searched for: Author "German Centre for Infection Research ( DZIF )" Remove constraint Author: "German Centre for Infection Research ( DZIF )" Database OpenAIRE Remove constraint Database: OpenAIRE
57 results on '"German Centre for Infection Research ( DZIF )"'

Search Results

1. EGF receptor modulates HEV entry in human hepatocytes

2. Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages

3. Erratum: Survival trade-offs in plant roots during colonization by closely related beneficial and pathogenic fungi

4. Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy

5. Prior flavivirus immunity skews the yellow fever vaccine response to expand cross-reactive antibodies with increased risk of antibody dependent enhancement of Zika and dengue virus infection

6. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies

7. Quantification of the Hepatitis B Virus cccDNA: Evidence-based guidelines for 2 monitoring the key obstacle of HBV cure 3 Short Title: cccDNA quantification harmonization 4 5

8. Plasmodium sporozoite disintegration during skin passage limits malaria parasite transmission

9. Rifapentine access in Europe:growing concerns over key tuberculosis treatment component

10. Wolbachiamodulates prevalence and viral load of Culex pipiens densoviruses in natural populations

11. Human Exposure to Hantaviruses Associated with Rodents of the Murinae Subfamily, Madagascar

12. Bloodstream Infections Caused by Magnusiomyces capitatus and Magnusiomyces clavatus : Epidemiological, Clinical, and Microbiological Features of Two Emerging Yeast Species

13. A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function

14. Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis

15. Access and benefit-sharing by the European Virus Archive in response to COVID-19

16. Towards the sustainable discovery and development of new antibiotics

17. Resurgence of Ebola Virus in 2021 in Guinea Suggests a New Paradigm for Outbreaks

18. Assessing excess mortality in times of pandemics based on principal component analysis of weekly mortality data—the case of COVID-19

19. COVID-19 infection in adult patients with hematological malignancies:a European Hematology Association Survey (EPICOVIDEHA)

20. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020

21. Repositories for Taxonomic Data: Where We Are and What is Missing

22. HIV DNA reservoir and elevated PD-1 expression of CD4 T-cell subsets particularly persist in the terminal ileum of HIV-positive patients despite cART

23. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry

24. Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe

25. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020

26. Cause-specific mortality after diagnosis of cancer among HIV-positive patients: a collaborative analysis of cohort studies

27. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group

28. The world's ten most feared fungi

29. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5: Entomological aspects

30. Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor

31. Detection of rat hepatitis E virus in wild Norway rats (Rattus norvegicus) and Black rats (Rattus rattus) from 11 European countries

32. Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1

33. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues

34. GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics

35. Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study

36. The amazing potential of fungi: 50 ways we can exploit fungi industrially

37. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

38. Revised interpretation of the Hain Lifescience GenoType MTBC to differentiate $Mycobacterium\ canettii$ and members of the $Mycobacterium\ tuberculosis$ Complex

39. HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial

40. Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology

41. Discovery of the first small-molecule CsrA–RNA interaction inhibitors using biophysical screening technologies

42. Minimal information for studies of extracellular vesicles 2018 (MISEV2018):a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

43. Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2018)

44. Dynamic Growth and Shrinkage of the Salmonella-Containing Vacuole Determines the Intracellular Pathogen Niche

45. Zika virus epidemiology in Bolivia : A seroprevalence study in volunteer blood donors

46. Identification of fungal fossils and novel azaphilone pigments in ancient carbonised specimens of Hypoxylon fragiforme from forest soils of Châtillon-sur-Seine (Burgundy)

47. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon

48. Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

49. Development of a Bead-Based Multiplex Assay for the Analysis of the Serological Response against the Six Pathogens HAV, HBV, HCV, CMV, T. gondii, and H. pylori

50. SC83288 is a clinical development candidate for the treatment of severe malaria

Catalog

Books, media, physical & digital resources